RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재 SCI SCIE SCOPUS

      Rescue Treatment with Intra-arterial Tirofiban Infusion and Emergent Carotid Stenting

      한글로보기

      https://www.riss.kr/link?id=A101617825

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      Rapid arterial rethrombosis is associated with high-grade residual stenosis and usually occurs at the site of the initial occlusion, resulting in reocclusion of the recanalized artery. Platelets may play an active role in such rethrombosis after thrombolytic-induced clot lysis. Given that glycoprotein IIb/IIIa receptor blockers, like tirofiban, prevent thrombus formation by inhibiting the final common pathway of platelet aggregation, they may be helpful for treating rethrombosis after thrombolysis. A 64-year-old man presented with an acute ischemic stroke due to internal carotid artery (ICA) occlusion. The ICA was recanalized by intravenous thrombolysis but reoccluded shortly after recanalization. The reoccluded ICA was successfully recanalized using intra-arterial tirofiban. A carotid stent was subsequently inserted to relieve severe stenosis and to prevent recurrent stroke. Here, we report a case of rescue treatment of a successfully recanalized ICA by intra- arterial tirofiban. We suggest that rescue use of intra-arterial tirofiban may be effective and safe, especially in hemorrhage prone situations, due to the relatively lower dose of tirofiban compared with intravenous doses.
      번역하기

      Rapid arterial rethrombosis is associated with high-grade residual stenosis and usually occurs at the site of the initial occlusion, resulting in reocclusion of the recanalized artery. Platelets may play an active role in such rethrombosis after throm...

      Rapid arterial rethrombosis is associated with high-grade residual stenosis and usually occurs at the site of the initial occlusion, resulting in reocclusion of the recanalized artery. Platelets may play an active role in such rethrombosis after thrombolytic-induced clot lysis. Given that glycoprotein IIb/IIIa receptor blockers, like tirofiban, prevent thrombus formation by inhibiting the final common pathway of platelet aggregation, they may be helpful for treating rethrombosis after thrombolysis. A 64-year-old man presented with an acute ischemic stroke due to internal carotid artery (ICA) occlusion. The ICA was recanalized by intravenous thrombolysis but reoccluded shortly after recanalization. The reoccluded ICA was successfully recanalized using intra-arterial tirofiban. A carotid stent was subsequently inserted to relieve severe stenosis and to prevent recurrent stroke. Here, we report a case of rescue treatment of a successfully recanalized ICA by intra- arterial tirofiban. We suggest that rescue use of intra-arterial tirofiban may be effective and safe, especially in hemorrhage prone situations, due to the relatively lower dose of tirofiban compared with intravenous doses.

      더보기

      참고문헌 (Reference)

      1 Liebeskind DS, "Vertebrobasilar thrombolysis with intravenous tirofiban: case report" 13 : 81-84, 2002

      2 The EPIC Investigators, "Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty" 330 : 956-961, 1994

      3 Seitz RJ, "The effect of combined thrombolysis with rtPA and tirofiban on ischemic brain lesions" 62 : 2110-2112, 2004

      4 Straub S, "Systemic thrombolysis with recombinant tissue plasminogen activator and tirofiban in acute middle cerebral artery occlusion" 35 : 705-709, 2004

      5 Lee KY, "Rescue treatment with abciximab in acute ischemic stroke" 56 : 1585-1587, 2001

      6 Qureshi AI, "Reocclusion of recanalized arteries during intra-arterial thrombolysis for acute ischemic stroke" 25 : 322-328, 2004

      7 Ho DS, "Intracarotid abciximab injection to abort impending ischemic stroke during carotid angioplasty" 11 : 300-304, 2001

      8 Heo JH, "Immediate reocclusion following a successful thrombolysis in acute stroke: a pilot study" 60 : 1684-1687, 2003

      9 Rukshin V, "Effects of GP IIb/IIIa receptor inhibitor tirofiban (aggrastat) in ex vivo canine arteriovenous shunt model of stent thrombosis" 41 : 615-624, 2003

      10 Wallace RC, "Basilar artery rethrombosis: successful treatment with platelet glycoprotein IIB/IIA receptor inhibitor" 18 : 1257-1260, 1997

      1 Liebeskind DS, "Vertebrobasilar thrombolysis with intravenous tirofiban: case report" 13 : 81-84, 2002

      2 The EPIC Investigators, "Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty" 330 : 956-961, 1994

      3 Seitz RJ, "The effect of combined thrombolysis with rtPA and tirofiban on ischemic brain lesions" 62 : 2110-2112, 2004

      4 Straub S, "Systemic thrombolysis with recombinant tissue plasminogen activator and tirofiban in acute middle cerebral artery occlusion" 35 : 705-709, 2004

      5 Lee KY, "Rescue treatment with abciximab in acute ischemic stroke" 56 : 1585-1587, 2001

      6 Qureshi AI, "Reocclusion of recanalized arteries during intra-arterial thrombolysis for acute ischemic stroke" 25 : 322-328, 2004

      7 Ho DS, "Intracarotid abciximab injection to abort impending ischemic stroke during carotid angioplasty" 11 : 300-304, 2001

      8 Heo JH, "Immediate reocclusion following a successful thrombolysis in acute stroke: a pilot study" 60 : 1684-1687, 2003

      9 Rukshin V, "Effects of GP IIb/IIIa receptor inhibitor tirofiban (aggrastat) in ex vivo canine arteriovenous shunt model of stent thrombosis" 41 : 615-624, 2003

      10 Wallace RC, "Basilar artery rethrombosis: successful treatment with platelet glycoprotein IIB/IIA receptor inhibitor" 18 : 1257-1260, 1997

      11 Alexandrov AV, "Arterial reocclusion in stroke patients treated with intravenous tissue plasminogen activator" 59 : 862-867, 2002

      더보기

      동일학술지(권/호) 다른 논문

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2023 평가예정 해외DB학술지평가 신청대상 (해외등재 학술지 평가)
      2020-01-01 평가 등재학술지 유지 (해외등재 학술지 평가) KCI등재
      2011-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2009-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2007-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2005-05-31 학술지등록 한글명 : Yonsei Medical Journal
      외국어명 : Yonsei Medical Journal
      KCI등재
      2005-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2002-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      2000-01-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 1.42 0.3 0.99
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.83 0.72 0.546 0.08
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼